Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy.
about
Cooling for newborns with hypoxic ischaemic encephalopathyPhysiologic and pharmacologic considerations for hypothermia therapy in neonates.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)Synergistic neuroprotective therapies with hypothermia.Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.A new neurological focus in neonatal intensive care.A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures.Clinical management of seizures in newborns : diagnosis and treatment.Neonatal seizures therapy: we are still looking for the efficacious drugMethods for pharmacokinetic analysis in young children.Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.Pitfalls in the quest of neuroprotectants for the perinatal brain.Plasma topiramate concentrations resulting from doses associated with neuroprotection against white matter injury and stroke in two strains of rat pups.Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia.Heart Rate and Arterial Pressure Changes during Whole-Body Deep Hypothermia.Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers.Propranolol concentrations after oral administration in term and preterm neonates.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study.Neonatal hypoxic ischaemic encephalopathy: current and future treatment options
P2860
Q24201494-9D4C8CAE-8DB7-4247-8D03-3091738611C5Q30422782-870409D9-E894-4E80-81F3-6D7894A1936CQ30462209-CA6B4DDF-3671-4C76-9A44-98FD831214B8Q33943360-18B0FFE3-F113-417B-AB86-92A378AFCFA7Q34239255-E1DC97B2-9696-48FE-93CF-C097DFD316EEQ34342674-0F4F6B3A-C065-4A7B-B537-3439A1193255Q36410220-1A3E8C75-B574-45CF-8736-712418097A3FQ36452379-38CC535D-7463-4D3A-961D-35C1B03FF906Q36620231-1474574E-5BB1-4174-B271-FEBC82278AE8Q37909914-0CF17C8D-16EE-4C0E-8C2B-AC37DB6BD33EQ38057226-1332CF34-5380-427C-B1ED-CEA206B99E3AQ38075488-FD6F8F33-5378-4E7B-A570-E59C089D6A18Q38112203-BD59923D-4A8D-44C8-8181-1AE2B89B0796Q38187157-528B65B8-187F-4C3E-8D34-717C40891900Q38645148-E7952573-8212-473D-8492-D564543E155AQ38760911-78DD2AEF-FF56-4E8C-B454-87F4674D10C6Q39413015-F151D972-44EE-453A-AFE0-1553C3922025Q39500601-71C6F98C-3FEF-4B44-ACF3-448ADD365257Q39735912-DA6ED123-CAEB-4315-AB4C-FC4A7FA390F0Q40565930-15BA4D83-B3EB-4E89-A1B0-AEC2BF03763EQ42692584-05FF9473-CCAF-4C55-A248-3345DC4D6FEDQ44663019-13E15DCD-FF59-410F-8B6B-DEA6A9D335EFQ50310697-40CC6473-B845-48A1-8EE6-4504DE11713EQ57405344-ACE93097-4222-41AA-A829-DFCA2AE0E7AD
P2860
Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@en
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@nl
type
label
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@en
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@nl
prefLabel
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@en
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@nl
P2093
P1433
P1476
Topiramate concentrations in n ...... poxic ischemic encephalopathy.
@en
P2093
Chiara Poggi
Domenico E Pellegrini-Giampietro
Giancarlo la Marca
Luca Filippi
Patrizio Fiorini
Renzo Guerrini
Sabrina Malvagia
P304
P356
10.1111/J.1528-1167.2009.02302.X
P577
2009-09-10T00:00:00Z